Close
Smartlab Europe
Achema middle east

News

BENEO presents sweet pharmaceutical excipient at CPhI

CPhI Worldwide, 5–7 November in Frankfurt a.M., is the perfect place to make new business contacts, strengthen existing relationships, discover state-of-the-art ingredients and meet BENEO’s expert team. Taking center stage on stand 102C11 is the company’s high quality, water-soluble...

WuXi STA’s Jinshan Facility Passes EMA Inspection

STA Pharmaceutical Co Ltd – a subsidiary of WuXi AppTec – announced that its Jinshan manufacturing facility in Shanghai, China has successfully passed an inspection by the European Medicines Agency (EMA) with no critical and no major findings. This...

The renewed Turkish Cargo Web Portal now offers you many conveniences with its new name ‘TK GO’

Turkish Cargo, the fastest-growing brand of the global air cargo industry, updated its web portal; a functional and user-friendly interface on Internet facilitating monitoring of all actions and providing the agents with customized solutions and facilitations. The renewed web portal...

FDA should withdraw ANDAs’,and ‘new technologies could bring massive improvements in efficiency’ if implemented correctly

CPhI Worldwide – the world’s largest pharma event taking place in Frankfurt (5th-7th November 2019) –has released the first part of its eponymous2019 Annual Report. Experts Bikash Chatterjee, President and Chief Science Officer at Pharmtech Associates and Girish Malhotra,...

Shionogi and Hsiri to develop mycobacterial disease therapies

Japanese pharmaceutical firm Shionogi has signed a licence agreement with Hsiri Therapeutics for the discovery and development of therapies for non-tuberculous mycobacterial (NTM) diseases, as well as tuberculosis (TB). The agreement covers a technology that will complement the company’s previous...

TriPharm Services announces creation of pharmaceutical manufacturing center

TriPharm Services, a new contract development and manufacturing organization (CDMO), is commissioning a new specialized manufacturing operation utilizing the latest isolator manufacturing equipment. The center of excellence specializes in injectable pharmaceutical capabilities including flexible manufacturing solutions for liquid and lyophilized...

Biocartis NV.: Biocartis Launches Liquid Biopsy Idylla ctEGFR Mutation Assay

Biocartis Group NV, an innovative molecular diagnostics company announces the launch of the Idylla ctEGFR Mutation Assay (RUO1). This assay is the liquid biopsy version of the solid biopsy Idylla™ EGFR Mutation Test (CE-IVD) and is further strengthening Biocartis’...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »